38063-90-0 Usage
General Description
2-[1-(4-aminophenyl)ethylideneamino]oxyacetic acid is a chemical compound with the molecular formula C10H13N3O3. It is a derivative of ethylideneamino and contains an amino group and a carboxylic acid group. 2-[1-(4-aminophenyl)ethylideneamino]oxyacetic acid is primarily used in research and pharmaceutical applications and has potential as a chelating agent due to its ability to form strong coordination complexes with metal ions. It may also have potential use as a contrast agent for imaging in medical diagnostics. Additionally, it may have potential as a potential therapeutic agent for treating various medical conditions, although further research is needed to fully understand its potential applications and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 38063-90-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,0,6 and 3 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 38063-90:
(7*3)+(6*8)+(5*0)+(4*6)+(3*3)+(2*9)+(1*0)=120
120 % 10 = 0
So 38063-90-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N2O3/c1-7(12-15-6-10(13)14)8-2-4-9(11)5-3-8/h2-5H,6,11H2,1H3,(H,13,14)/b12-7-
38063-90-0Relevant articles and documents
Oxime ether derivatives, a new class of nonsteroidal antiinflammatory compounds
Van Dijk,Zwagemakers
, p. 1199 - 1206 (2007/10/07)
A series of new 2-hydroxyethyl and carboxyalkyl ethers of aromatic oximes was found to possess pronounced antiinflammatory activity in the carrageenan-induced edema test in the rat. The activity was limited mainly to derivatives of p-haloacetophenone oxime and of p-halobenzaldehyde oxime. Nevertheless the hydroxyethyl and carboxyalkyl groups may be converted into many derivatives with maintenance of activity. Some structure-activity relationships are in contrast to those of the well-known antiinflammatory arylacetic acids. The activity is limited to the E stereoisomers. The hydrochloride of 2-(dimethylamino)ethyl (E)-[[(p-chloro-α- methylbenzylidene)-amino]oxy]acetate (36, INN name Cloximate) was cosen for clinical evaluation. The first results agree with the pharmacological prospects.
